Core Insights - Smackover Lithium, a joint venture between Standard Lithium and Equinor, has achieved a significant technical milestone in the South West Arkansas project, confirming the engineering design for commercialization [1][3] - The DLE field-pilot plant has successfully surpassed key performance criteria, recovering over 99% of lithium from brine, which is significantly higher than the design target of 95% [4] Project Development - The DLE field-pilot plant operated for three months, processing over 2,385 barrels (100,170 gallons) of brine from the IPC-1 well, completing over 497 DLE cycles [4] - The project has processed a total of 28,367,185 gallons of brine and completed 11,206 cycles of DLE at the Demonstration Plant since 2020 [4] Product Qualification - Large volumes of concentrated and purified DLE product have been sent to third-party vendors for conversion into battery-quality lithium carbonate, which will be used in the qualification process with potential off-take partners [1][4] - Approximately 970 gallons (3,672 liters) of a 6% lithium chloride solution has been produced, with expectations of generating around 27 kg of battery-quality lithium carbonate by May 2025 [4] Technology and Operations - The DLE technology utilized in the field-pilot plant is based on KTS Li-ProTM Lithium Selective Sorption technology, which has been instrumental in optimizing the extraction process [4] - Standard Lithium has been operating a large-scale Demonstration Plant in Arkansas for five years, processing over 28 million gallons of Smackover brine, which has been crucial for developing and streamlining the extraction flowsheet [3]

Core Viewpoint - Stocks priced under $10 offer an attractive entry point for investors looking to diversify their portfolios and maximize growth potential without significant capital outlay [1] Group 1: Ford Motor Company - Ford Motor Company is currently trading at $9.98 with a dividend yield of 6.02% and a P/E ratio of 6.83, indicating strong value [2][3] - The company reported record revenue of $185 billion for the full year of 2024 and has a positive outlook for 2025, with significant investments in electric vehicle (EV) infrastructure totaling up to $50 billion by 2026 [3] - Ford aims to achieve 2 million annual EV sales by 2026 while maintaining its internal combustion engine vehicle business [3] Group 2: Nokia Oyj - Nokia Oyj is trading at $5.14 with a dividend yield of 1.55% and a P/E ratio of 20.58, positioning it as a key player in telecommunications [5] - The company exceeded Q4 2024 earnings expectations and projects a Comparable Operating Profit between $2.1 billion and $2.7 billion for 2025, alongside strong free cash flow [6] - Nokia's leadership in 5G infrastructure and expansion into high-growth markets like data center networking enhances its revenue diversification [7] Group 3: Goodyear Tire & Rubber Company - Goodyear is currently priced at $9.67 with a P/E ratio of 40.29, indicating potential undervaluation [8][9] - The company reported a full-year 2024 segment operating income of $1.318 billion, reflecting a $350 million year-over-year increase, driven by its "Goodyear Forward" transformation plan [11] - Goodyear aims to achieve $1.5 billion in annual run-rate benefits by the end of 2025 through cost reductions and margin expansion [10] Group 4: Standard Lithium Ltd. - Standard Lithium is trading at $1.23 with a P/E ratio of 2.08, representing a high-risk, high-reward investment opportunity in the EV battery supply chain [12] - The company focuses on innovative Direct Lithium Extraction technology and has received a conditional $225 million grant from the U.S. Department of Energy for its South West Arkansas Project [14] - Standard Lithium's projects in Arkansas position it well to meet the surging demand for lithium in EV batteries [13] Group 5: Mereo BioPharma Group - Mereo BioPharma is priced at $2.45 and focuses on developing drug candidates for rare diseases, presenting a high-risk, high-reward investment opportunity [15] - The company's pipeline includes late-stage candidates Setrusumab and Alvelestat, with Setrusumab receiving Breakthrough Therapy Designation from the U.S. FDA [16] - Mereo has a cash runway extending into 2027, providing financial stability for its clinical programs [17] Group 6: Investment Opportunities - The five identified companies, all priced under $10, present compelling investment opportunities for Q2 2025, with established firms like Ford and Goodyear offering potential value and dividends, while Nokia, Standard Lithium, and Mereo BioPharma represent higher-risk, higher-reward prospects [18]

Core Insights - Standard Lithium Ltd. is a leading near-commercial lithium developer focused on sustainable lithium production [2] - The company will participate in the 37th Annual Roth Conference from March 16 to 18, 2025, in Dana Point, California [1] Company Overview - Standard Lithium is dedicated to the sustainable development of high-grade lithium-brine properties in the United States [2] - The company prioritizes projects with high-quality resources, robust infrastructure, skilled labor, and streamlined permitting [2] - Its flagship projects are located in the Smackover Formation in Arkansas and Texas, with a focus on commercial-scale lithium production using Direct Lithium Extraction (DLE) [2] - Standard Lithium is advancing the South West Arkansas project in partnership with Equinor and the Phase 1A project with LANXESS Corporation [2] - The company also holds interests in mineral leases in the Mojave Desert, California [2] Event Participation - Senior leadership, including the CFO and Director of Finance, will host one-on-one meetings during the Roth Conference [1] - Interested investors can contact Standard Lithium's Investor Relations for more information [1]